Gilead Sciences, Inc. (NASDAQ:GILD) Q1 2024 Earnings Call Tr

Gilead Sciences, Inc. beats earnings expectations. Reported EPS is $-1.32, expectations were $-1.49. Gilead Sciences, Inc.

Related Keywords

Maryland , United States , Tennessee , Japan , America , Jacquie Ross , Salveen Richter , Daina Graybosch , Chris Schott , Merdad Parsey , Johanna Mercier , Tyler Van Buren , Andrew Dickinson , Geoff Meacham , Goldman Sachs , Cindy Perettie , James Shin , Mohit Bansal , Cindy Poretti , Michael Yee , James Shin At Deutsche Bank , Gilead Sciences Inc , Geoff Meacham At Bank , Nasdaq , Department Of Corrections , Gilead Sciences , Call Transcript April , First Quarter , Investor Relations , Corporate Strategic , Chief Executive Officer , Danielo Day , Chief Commercial Officer , Chief Medical Officer , Chief Financial Officer , Executive Vice President , Cymabay Acquisition , Change Healthcare , Tennessee Oncology , Popular Retail Investor Stocks , Radar Stocks With Massive Upside , Umer Raffat , Van Buren , Thanks Tyler , Maybei Ll ,